TRANSVERSAL UNITS

FOLLOWING THE SAME PATH

The CIPF Transversal Units bring together key research areas that work in an interconnected way to tackle scientific challenges from different perspectives. These units combine knowledge, technology, and innovation to drive progress in bioengineering and cell therapy, computational biology and data science, drug discovery and nanomedicine, and preclinical models of disease. Their multidisciplinary and collaborative approach enables the development of more effective and applicable solutions for science and health.

BIOENGINEERING & CELL THERAPY

Focuses on cell behaviour & tissue bioengineering.

COMPUTATIONAL BIOLOGY & DATA SCIENCE

Focuses on advance of high-throughput technologies & potential of computational approaches. The aim of this transversal unit is the development of computational methods and tools to relate phenotypic and molecular characteristics in the disease groups of the scientific programmes of the CIPF.The study of sex and gender differences in these pathologies, through the massive analysis and integration of omics, clinical and imaging data, and the use of artificial intelligence methods.

DRUG DISCOVERY & NANOMEDICINE​

Works on the identification of innovative drugs based on druggable targets & their pharmacological improvement by means of nanomedicine. Provides strategic technology services to design new drugs, aligning the main goals of the CIPF programs that converge to offer personalized solutions to patients based on molecular knowledge of the disease.
This occurs in the context of European standards as we are an accredited specialized screening site from the European Research infrastructure, EU OPENSCREEN.

PRECLINICAL MODELS OF DISEASE

Generation of in vitro and in vivo disease models relevant to various research programs. The animal facility (>1000 m2) provides high quality animal care services and equipment to ensure consistency and reproducibility of data from in vivo preclinical animal models. This pathogen-free animal facility, together with the veterinary team and the Animal Ethics and Experimentation Committee, ensures compliance with legal regulations and high ethical standards in animal welfare.

The facility includes specialized areas and scientific equipment for preclinical animal model experimentation. The Transgenic Production Unit is responsible for generating preclinical models and cryopreserving existing ones, with experience in CRISPR/Cas techniques.